AnnouncementsPanacea Biotec: Board meeting on August 01, 2014
100% of moneycontrol users recommend buying Panacea Biotec.
What's your call on Panacea Biotec today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2801.90||-0.72||2939.80||2140.35||47,726.17|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|ICICI Prudential Exports and Other Services Fund (G)||307,268|
|ICICI Prudential Exports and Other Services Fund - Direct Plan (G)||15,302|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Panacea Biotec is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,028.09 crore.The company has reported a standalone sales of Rs 156.15 crore and a Net Profit of Rs 33.98 crore for the quarter ended Mar 2014.
The company management includes Soshil Kumar Jain - Chairman, Ravinder Jain - Managing Director, Rajesh Jain - Joint Managing Director, Sandeep Jain - Joint Managing Director, Sumit Jain - Director, R L Narasimhan - Independent Director, N N Khamitkar - Independent Director, Sunil Kapoor - Independent Director, K M Lal - Independent Director, A N Saksena - Independent Director.
It is listed on the BSE with a BSE Code of 531349 and the NSE with an NSE Code of PANACEABIO.
Its Registered office is at Ambala-Chandigarh Highway , Lalru,Punjab - 140501.
Their Registrars are Skyline Financial Services (p) Ltd.